Blood management

The Patient Blood Management ( PBM) is an individual treatment plan for the reduction and prevention of anemia and blood loss as well as the rational use of blood products dar.

When PBM is a clinical, multidisciplinary, patient- centered approach that includes primarily the treatment or prevention of anemia, the reduction of blood loss and increasing anemia tolerance. Only after exhausting these therapeutic options transfusion of allogeneic blood products is considered. Other than that, the EU initiated Optimal Blood Use Project ( EUOBUP ), which it the right blood product targeted to the right patient at the right time to administer, is the PBM a step further and tried to take a preventive and corrective influence on those risk factors that usually lead to transfusions. The application of the PBM concept, is indicated not only for the perioperative phase, but for all areas of medicine, which deal with the treatment of blood and blood products. The overall objective of PBM is to improve the patient's outcome.

Origin of the Patient Blood Management

PBM was developed using data from the first Austrian benchmark study together with international experts and is now being implemented in Western Australia and in a number of American and European centers. It was recorded in 2010 as an important principle to improve transfusion safety in the agenda of the WHO and the website of the American Association of Blood Banks ( AABB ).

Objectives of the Patient Blood Management

In addition to the preoperative treatment of anemia and the improved use of packed red blood cells in the case of transfusion, as well as the minimization of diagnostic and interventional blood loss, it is one of the objectives of the PBMs, including the prevention and treatment of coagulopathy and thus a patient-oriented application of coagulation preparations and platelet concentrates to establish.

In the center of the PBM project focuses on the following three main treatment goals: